ARCHIVES

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

House-Senate conferees Decide On $733.5 Million (Plus Training Funds) For NCI In 1976

October 31, 1975

NIH Sets Tuition Cost Policy For NRSA Grants

February 9, 1996

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

June 14, 2013

Myriad In Partnership To Market Products.

December 14, 2001

NCAB Settles PDQ Controversy; More CCOP Awards May Be Made, Center Guidelines Revisions Coming

October 7, 1983